RxDoctor Payments Data

Mary Minsky, PA

Physician Assistant · Lake Village, ARNPI 1619286150

Payments from drug & device makers

$614in general payments, 2019–2025

Across 35 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$77
  • AbbVie$76
  • Baxter Healthcare$66
  • Boehringer Ingelheim$58
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$49
  • Dexcom, Inc.$36
  • plus $251 from 12 others

What the payments were for

  • Food & beverage$614100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$614 in reported general payments places this provider in the 55th percentile of 451 physician assistant providers in Arkansas.

See all physician assistant providers in Arkansas

Medicare billing

Part B allowed, 2024
$506
Medicare patients
16
Services billed
18

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin93$66,473
OzempicSemaglutide50$52,204
TrulicityDulaglutide22$35,836
XareltoRivaroxaban35$31,418
EliquisApixaban38$26,388
Synjardy XrEmpagliflozin/Metformin Hcl20$22,408
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$21,075
LinzessLinaclotide35$19,090
EntrestoSacubitril/Valsartan19$10,998
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$9,265
SynjardyEmpagliflozin/Metformin Hcl13$8,024
Tresiba Flextouch U-100Insulin Degludec14$7,693
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$7,154
Clonidine32$4,991
VascepaIcosapent Ethyl12$4,638

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr, Synjardy$58$96,904126 claims
Novo NordiskOzempic$20$52,20450 claims
Lilly USA, LLCTrulicity$77$35,83622 claims
GSKTrelegy Ellipta, Anoro Ellipta$13$28,22940 claims
PfizerEliquis$25$26,38838 claims
AbbVieLinzess$76$19,09035 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 451 physician assistant providers in Arkansas.

Other physician assistant in Lake Village

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →